Spontaneous resolution of post-transplant localized cytomegalovirus lymphadenitis mimicking tumor recurrence

K. W. Kang, Ju-Han Lee, J. S. Choi, Se Ryeon Lee, Yong Park, Byung Soo Kim, I. Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Compromised T-cell immunity persists for up to 1 year after autologous stem cell transplantation (ASCT), and patients treated with ASCT are more likely to develop atypical lymphoid hyperplasia that mimics tumor recurrence. Here, we present a case of cervical lymphadenitis due to cytomegalovirus (CMV) reactivation in a patient who had undergone ASCT for Burkitt lymphoma, which mimicked tumor recurrence on computed tomography and positron emission tomography-computed tomography 6 months after ASCT. This lesion was confined to the regional lymph nodes and was not accompanied by signs of systemic involvement, such as fever, splenomegaly, an elevated C-reactive protein level, or viremia. The localized CMV lymphadenitis resolved spontaneously without treatment after 6 months (12 months after ASCT) and the elevated CMV immunoglobulin-M titer normalized 6 months after resolution. Our experience with this case suggests that cautious follow-up without anti-CMV treatment should be considered in cases of post-ASCT localized CMV lymphadenitis without systemic involvement in patients with complete engraftment.

Original languageEnglish
Pages (from-to)676-680
Number of pages5
JournalTransplant Infectious Disease
Volume16
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Lymphadenitis
Stem Cell Transplantation
Cytomegalovirus
Transplants
Recurrence
Neoplasms
Burkitt Lymphoma
Viremia
Splenomegaly
C-Reactive Protein
Hyperplasia
Immunoglobulin M
Immunity
Fever
Lymph Nodes
Tomography
T-Lymphocytes
Therapeutics

Keywords

  • Atypical lymphoid hyperplasia
  • Autologous stem cell transplantation
  • CMV
  • Cytomegalovirus lymphadenitis

ASJC Scopus subject areas

  • Transplantation
  • Infectious Diseases
  • Medicine(all)

Cite this

@article{1b29f2ac3f0b4d2a8cfbd3ae7cb62e0b,
title = "Spontaneous resolution of post-transplant localized cytomegalovirus lymphadenitis mimicking tumor recurrence",
abstract = "Compromised T-cell immunity persists for up to 1 year after autologous stem cell transplantation (ASCT), and patients treated with ASCT are more likely to develop atypical lymphoid hyperplasia that mimics tumor recurrence. Here, we present a case of cervical lymphadenitis due to cytomegalovirus (CMV) reactivation in a patient who had undergone ASCT for Burkitt lymphoma, which mimicked tumor recurrence on computed tomography and positron emission tomography-computed tomography 6 months after ASCT. This lesion was confined to the regional lymph nodes and was not accompanied by signs of systemic involvement, such as fever, splenomegaly, an elevated C-reactive protein level, or viremia. The localized CMV lymphadenitis resolved spontaneously without treatment after 6 months (12 months after ASCT) and the elevated CMV immunoglobulin-M titer normalized 6 months after resolution. Our experience with this case suggests that cautious follow-up without anti-CMV treatment should be considered in cases of post-ASCT localized CMV lymphadenitis without systemic involvement in patients with complete engraftment.",
keywords = "Atypical lymphoid hyperplasia, Autologous stem cell transplantation, CMV, Cytomegalovirus lymphadenitis",
author = "Kang, {K. W.} and Ju-Han Lee and Choi, {J. S.} and Lee, {Se Ryeon} and Yong Park and Kim, {Byung Soo} and I. Kim",
year = "2014",
doi = "10.1111/tid.12254",
language = "English",
volume = "16",
pages = "676--680",
journal = "Transplant Infectious Disease",
issn = "1398-2273",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Spontaneous resolution of post-transplant localized cytomegalovirus lymphadenitis mimicking tumor recurrence

AU - Kang, K. W.

AU - Lee, Ju-Han

AU - Choi, J. S.

AU - Lee, Se Ryeon

AU - Park, Yong

AU - Kim, Byung Soo

AU - Kim, I.

PY - 2014

Y1 - 2014

N2 - Compromised T-cell immunity persists for up to 1 year after autologous stem cell transplantation (ASCT), and patients treated with ASCT are more likely to develop atypical lymphoid hyperplasia that mimics tumor recurrence. Here, we present a case of cervical lymphadenitis due to cytomegalovirus (CMV) reactivation in a patient who had undergone ASCT for Burkitt lymphoma, which mimicked tumor recurrence on computed tomography and positron emission tomography-computed tomography 6 months after ASCT. This lesion was confined to the regional lymph nodes and was not accompanied by signs of systemic involvement, such as fever, splenomegaly, an elevated C-reactive protein level, or viremia. The localized CMV lymphadenitis resolved spontaneously without treatment after 6 months (12 months after ASCT) and the elevated CMV immunoglobulin-M titer normalized 6 months after resolution. Our experience with this case suggests that cautious follow-up without anti-CMV treatment should be considered in cases of post-ASCT localized CMV lymphadenitis without systemic involvement in patients with complete engraftment.

AB - Compromised T-cell immunity persists for up to 1 year after autologous stem cell transplantation (ASCT), and patients treated with ASCT are more likely to develop atypical lymphoid hyperplasia that mimics tumor recurrence. Here, we present a case of cervical lymphadenitis due to cytomegalovirus (CMV) reactivation in a patient who had undergone ASCT for Burkitt lymphoma, which mimicked tumor recurrence on computed tomography and positron emission tomography-computed tomography 6 months after ASCT. This lesion was confined to the regional lymph nodes and was not accompanied by signs of systemic involvement, such as fever, splenomegaly, an elevated C-reactive protein level, or viremia. The localized CMV lymphadenitis resolved spontaneously without treatment after 6 months (12 months after ASCT) and the elevated CMV immunoglobulin-M titer normalized 6 months after resolution. Our experience with this case suggests that cautious follow-up without anti-CMV treatment should be considered in cases of post-ASCT localized CMV lymphadenitis without systemic involvement in patients with complete engraftment.

KW - Atypical lymphoid hyperplasia

KW - Autologous stem cell transplantation

KW - CMV

KW - Cytomegalovirus lymphadenitis

UR - http://www.scopus.com/inward/record.url?scp=84905578588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905578588&partnerID=8YFLogxK

U2 - 10.1111/tid.12254

DO - 10.1111/tid.12254

M3 - Article

VL - 16

SP - 676

EP - 680

JO - Transplant Infectious Disease

JF - Transplant Infectious Disease

SN - 1398-2273

IS - 4

ER -